Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.22−0.03 (-13.03%)
Close on Nov 16, 2026Market cap $1.41MP/E –Yield –
Co-Diagnostics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Co-Diagnostics's free cash flow for the twelve months ending Jun 30, 2026 was -$27.47M. For fiscal 2025 it was -$29.84M. The highest annual figure on record is $40.41M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.84M | – |
| FY2024 | Dec 31, 2024 | -$29.90M | – |
| FY2023 | Dec 31, 2023 | -$23.45M | -556.1% |
| FY2022 | Dec 31, 2022 | $5.14M | -87.3% |
| FY2021 | Dec 31, 2021 | $40.41M | +47.5% |
| FY2020 | Dec 31, 2020 | $27.39M | – |
| FY2019 | Dec 31, 2019 | -$5.64M | – |
| FY2018 | Dec 31, 2018 | -$4.12M | – |
| FY2017 | Dec 31, 2017 | -$3.34M | – |
| FY2016 | Dec 31, 2016 | -$1.32M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.99M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.98M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.84M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.40M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.30M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.00M | -775.7% |
| Q2 FY2023 | Jun 30, 2023 | -$6.10M | -632.3% |
| Q1 FY2023 | Mar 31, 2023 | -$6.10M | -182.3% |
| Q4 FY2022 | Dec 31, 2022 | -$4.30M | -190.5% |
| Q3 FY2022 | Sep 30, 2022 | $888.27K | -92.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.15M | -90.6% |
| Q1 FY2022 | Mar 31, 2022 | $7.41M | -38.9% |
| Q4 FY2021 | Dec 31, 2021 | $4.76M | -75.6% |
| Q3 FY2021 | Sep 30, 2021 | $11.34M | +34.2% |
| Q2 FY2021 | Jun 30, 2021 | $12.18M | +1280.9% |
| Q1 FY2021 | Mar 31, 2021 | $12.13M | – |
| Q4 FY2020 | Dec 31, 2020 | $19.49M | – |
| Q3 FY2020 | Sep 30, 2020 | $8.46M | – |
| Q2 FY2020 | Jun 30, 2020 | $882.15K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.44M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.65M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$999.47K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.18M | – |
| Q2 FY2018 | Jun 30, 2018 | -$967.98K | – |
| Q1 FY2018 | Mar 31, 2018 | -$978.21K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.03M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.55M | – |
| Q2 FY2017 | Jun 30, 2017 | -$294.43K | – |
| Q1 FY2017 | Mar 31, 2017 | -$460.78K | – |
| Q4 FY2016 | Dec 31, 2016 | -$560.64K | – |
| Q3 FY2016 | Sep 30, 2016 | -$298.06K | – |
See a number that looks wrong?